Treatment of polyarteritis nodosa: comment on the article by Guillevin et al.
Christian
Charles L
CL
D003520:Cyclophosphamide / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006509:Hepatitis B / Q000150:complications / Q000473:pathology / Q000628:therapy; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D010951:Plasma Exchange; D010488:Polyarteritis Nodosa / Q000175:diagnosis / Q000628:therapy / Q000821:virology; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D005938:Glucocorticoids; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D003520:Cyclophosphamide